Danaher Stock - weekly sector check and peer comparison
Published on 06/19/2026 at 15:26 | Editorial responsibility: Rafael MĂŒller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 13:24 UTC. Details in the imprint.
Danaher (US2358511028) remains a core name in the US life-sciences and diagnostics sector, with the stock trading in a narrow range this week on the New York Stock Exchange. Investors continue to benchmark the group against large-cap peers in tools, diagnostics and industrial technology.
All news and key data on Danaher stock
Current articles, price data and regulatory filings on Danaher stock can be found bundled on the ad hoc news topic page and in the companyâs own investor-relations section.
How Danaher closed the week
Danaher shares last closed at $177.74 on 06/18/2026, essentially unchanged on the day according to price data compiled by MarketBeat. That level leaves the stock broadly mid-range compared with its trading band over recent months.
Extended trading on the same date showed Danaher shares at $177.53, a marginal 0.1% move below the regular session close. The muted action underlines a lack of fresh company-specific catalysts in the past few days.
Positioning versus life-science peers
Within the broader life-sciences tools and diagnostics group, Danaher is often discussed alongside large US peers such as Thermo Fisher Scientific and Abbott Laboratories in analyst sector work. The shared exposure includes bioprocessing, laboratory instruments and clinical diagnostics.
On balance, the sector backdrop in 2026 remains mixed, with soft biopharma capital spending offset by stable demand in clinical diagnostics and water-quality solutions. Against this backdrop, investors are comparing balance-sheet flexibility and margin resilience across the peer group.
Where Danaher generates its revenue
Danaher derives revenue from a portfolio of life sciences, diagnostics and biotechnology businesses, including platforms such as Cytiva bioprocessing equipment, Beckman Coulter clinical analyzers and Leica branded microscopes used in research and healthcare laboratories.
Where the stock trades today
The shares of Danaher (US2358511028) trade on the New York Stock Exchange at $177.74 as of 06/18/2026, 15:59 Eastern Time.
Key facts on Danaher stock
- Company: Danaher Corp.
- ISIN: US2358511028
- WKN: 866197
- Ticker: DHR
- Venue: NYSE
- Price (as of 06/18/2026, 15:59 Eastern Time): 177.74 USD
- Market cap: 131,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Life Sciences Tools & Services
- Index membership: S&P 500
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
